BackgroundUsing blood specimens from untreated early Parkinson's disease (PD) patients from the DATATOP trial, we found that subjects in the low serum vitamin B12 tertile experienced greater annualized change in ambulatory capacity score, whereas those with moderately elevated (>15 μmol/L) total homocysteine had greater annualized declines in the Mini-Mental State Exam.MethodsIn this this study we sought to determine whether levels of cerebrospinal fluid (CSF) B12 markers were also associated with progression of PD.ResultsThe annualized change in the UPDRS "walking" item, a component of the ambulatory capacity score, was worse in the low B12 tertile. No association with change in the Mini-Mental State Exam was seen for those 7% with the ...
Hyperhomocysteinemia is considered an independent risk factor for cognitive impairment. To study the...
B vitamins may correlate with Parkinson’s disease (PD) through regulating homocysteine level. Howeve...
In clinical studies, individuals with Parkinson’s disease have had higher concentrations of plasma h...
BackgroundUsing blood specimens from untreated early Parkinson's disease (PD) patients from the DATA...
ObjectiveIn Parkinson's disease (PD), vitamin B12 levels are lower, and comorbid B12 deficiency has ...
BackgroundVitamin B12 deficiency causes a number of neurological features including cognitive and ps...
Background: Studies attempting to elucidate an association between homocysteine and symptom progress...
Background: Plasma homocysteine (Hcy) levels are increased in patients with Parkinson’s disease (PD)...
Introduction: Mild Cognitive Impairment in Parkinson’s Disease (PD-MCI) is a transitional state betw...
OBJECTIVE To investigate the correlation between serum homocysteine (Hcy) and cognitive impairment (...
Background: Plasma homocysteine (Hcy) levels are increased in patients with Parkinson’s disease (PD...
Abstract: Objective: To assess the prevalence of hyperhomocysteinemia in Parkinson’s Disease (PD) an...
Factors related with hyperhomocysteinemia (HHcy) and the impact of HHcy in Parkinson’s disease (PD) ...
Background. Homocysteine (Hcy) levels were higher in patients with Parkinson’s disease (PD). This co...
Background: Studies attempting to elucidate an association between homocysteine and symptom progress...
Hyperhomocysteinemia is considered an independent risk factor for cognitive impairment. To study the...
B vitamins may correlate with Parkinson’s disease (PD) through regulating homocysteine level. Howeve...
In clinical studies, individuals with Parkinson’s disease have had higher concentrations of plasma h...
BackgroundUsing blood specimens from untreated early Parkinson's disease (PD) patients from the DATA...
ObjectiveIn Parkinson's disease (PD), vitamin B12 levels are lower, and comorbid B12 deficiency has ...
BackgroundVitamin B12 deficiency causes a number of neurological features including cognitive and ps...
Background: Studies attempting to elucidate an association between homocysteine and symptom progress...
Background: Plasma homocysteine (Hcy) levels are increased in patients with Parkinson’s disease (PD)...
Introduction: Mild Cognitive Impairment in Parkinson’s Disease (PD-MCI) is a transitional state betw...
OBJECTIVE To investigate the correlation between serum homocysteine (Hcy) and cognitive impairment (...
Background: Plasma homocysteine (Hcy) levels are increased in patients with Parkinson’s disease (PD...
Abstract: Objective: To assess the prevalence of hyperhomocysteinemia in Parkinson’s Disease (PD) an...
Factors related with hyperhomocysteinemia (HHcy) and the impact of HHcy in Parkinson’s disease (PD) ...
Background. Homocysteine (Hcy) levels were higher in patients with Parkinson’s disease (PD). This co...
Background: Studies attempting to elucidate an association between homocysteine and symptom progress...
Hyperhomocysteinemia is considered an independent risk factor for cognitive impairment. To study the...
B vitamins may correlate with Parkinson’s disease (PD) through regulating homocysteine level. Howeve...
In clinical studies, individuals with Parkinson’s disease have had higher concentrations of plasma h...